Literature DB >> 18719599

Regulation of food intake and energy expenditure by hypothalamic malonyl-CoA.

M D Lane1, M Wolfgang, S-H Cha, Y Dai.   

Abstract

Energy balance is monitored by the hypothalamus. Malonyl-CoA, an intermediate in fatty acid synthesis, serves as an indicator of energy status in the hypothalamic neurons. The cellular malonyl-CoA level is determined by its rate of synthesis, catalyzed by acetyl-CoA carboxylase (ACC), and rate of removal, by fatty acid synthase (FAS). Malonyl-CoA functions in the hypothalamic neurons that express orexigenic and anorexigenic neuropeptides. Inhibitors of FAS, administered systemically or intracerebroventricularly to mice, increase hypothalamic malony-CoA and suppress food intake. Recent evidence suggests that the changes of hypothalamic malonyl-CoA during feeding and fasting cycles are caused by changes in the phosphorylation state and activity of ACC mediated via 5'-AMP-activated protein kinase (AMPK). Stereotactic delivery of a viral malonyl-CoA decarboxylase (MCD) vector into the ventral hypothalamus lowers malonyl-CoA and increases food intake. Fasting decreases hypothalamic malonyl-CoA and refeeding increases hypothalamic malonyl-CoA, to alter feeding behavior in the predicted manner. Malonyl-CoA level is under the control of AMP kinase which phosphorylates/inactivates ACC. Malonyl-CoA is an inhibitor of carnitine palmitoyl-CoA transferase-1 (CPT1), an outer mitochondrial membrane enzyme that regulates entry into, and oxidation of fatty acids, by mitochondria. CPT1c, a recently discovered, brain-specific enzyme expressed in the hypothalamus, has high sequence similarity to liver/muscle CPT1a/b and binds malonyl-CoA, but does not catalyze the prototypical reaction. This suggests that CPT1c has a unique function or activation mechanism. CPT1c knockout (KO) mice have lower food intake, weigh less and have less body fat, consistent with the role as an energy-sensing malonyl-CoA target. Paradoxically, CPT1c protects against the effects of a high-fat diet. CPT1cKO mice exhibit decreased rates of fatty acid oxidation, consistent with their increased susceptibility to diet-induced obesity. We suggest that CPT1c may be a downstream target of malonyl-CoA that regulates energy homeostasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18719599     DOI: 10.1038/ijo.2008.123

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  13 in total

1.  A potential role for adjunctive vitamin D therapy in the management of weight gain and metabolic side effects of second-generation antipsychotics.

Authors:  Benjamin U Nwosu; Bruce Meltzer; Louise Maranda; Carol Ciccarelli; Daniel Reynolds; Laura Curtis; Jean King; Jean A Frazier; Mary M Lee
Journal:  J Pediatr Endocrinol Metab       Date:  2011       Impact factor: 1.634

2.  Recombinant yeast screen for new inhibitors of human acetyl-CoA carboxylase 2 identifies potential drugs to treat obesity.

Authors:  Jasmina Marjanovic; Dominika Chalupska; Caroline Patenode; Adam Coster; Evan Arnold; Alice Ye; George Anesi; Ying Lu; Ilya Okun; Sergey Tkachenko; Robert Haselkorn; Piotr Gornicki
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

3.  Ribosomal protein-Mdm2-p53 pathway coordinates nutrient stress with lipid metabolism by regulating MCD and promoting fatty acid oxidation.

Authors:  Yong Liu; Yizhou He; Aiwen Jin; Andrey P Tikunov; Lishi Zhou; Laura A Tollini; Patrick Leslie; Tae-Hyung Kim; Lei O Li; Rosalind A Coleman; Zhennan Gu; Yong Q Chen; Jeffrey M Macdonald; Lee M Graves; Yanping Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-28       Impact factor: 11.205

Review 4.  Structure and function of biotin-dependent carboxylases.

Authors:  Liang Tong
Journal:  Cell Mol Life Sci       Date:  2012-08-07       Impact factor: 9.261

Review 5.  The role of hypothalamic H1 receptor antagonism in antipsychotic-induced weight gain.

Authors:  Meng He; Chao Deng; Xu-Feng Huang
Journal:  CNS Drugs       Date:  2013-06       Impact factor: 5.749

6.  Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation.

Authors:  Johan Fernø; Luis Varela; Silje Skrede; María Jesús Vázquez; Rubén Nogueiras; Carlos Diéguez; Antonio Vidal-Puig; Vidar M Steen; Miguel López
Journal:  PLoS One       Date:  2011-06-13       Impact factor: 3.240

7.  Crystal structures of malonyl-coenzyme A decarboxylase provide insights into its catalytic mechanism and disease-causing mutations.

Authors:  D Sean Froese; Farhad Forouhar; Timothy H Tran; Melanie Vollmar; Yi Seul Kim; Scott Lew; Helen Neely; Jayaraman Seetharaman; Yang Shen; Rong Xiao; Thomas B Acton; John K Everett; Giuseppe Cannone; Sriharsha Puranik; Pavel Savitsky; Tobias Krojer; Ewa S Pilka; Wasim Kiyani; Wen Hwa Lee; Brian D Marsden; Frank von Delft; Charles K Allerston; Laura Spagnolo; Opher Gileadi; Gaetano T Montelione; Udo Oppermann; Wyatt W Yue; Liang Tong
Journal:  Structure       Date:  2013-06-20       Impact factor: 5.006

8.  Ethanol extracts of chickpeas alter the total lipid content and expression levels of genes related to fatty acid metabolism in mouse 3T3-L1 adipocytes.

Authors:  Shigeo Shinohara; Yuanjun Gu; Ying Yang; Yasuo Furuta; Masahiko Tanaka; Xiaohua Yue; Weiqing Wang; Masaru Kitano; Hiroshi Kimura
Journal:  Int J Mol Med       Date:  2016-06-24       Impact factor: 4.101

9.  Long-term increased carnitine palmitoyltransferase 1A expression in ventromedial hypotalamus causes hyperphagia and alters the hypothalamic lipidomic profile.

Authors:  Paula Mera; Joan Francesc Mir; Gemma Fabriàs; Josefina Casas; Ana S H Costa; Maria Ida Malandrino; José-Antonio Fernández-López; Xavier Remesar; Su Gao; Shigeru Chohnan; Maria Sol Rodríguez-Peña; Harald Petry; Guillermina Asins; Fausto G Hegardt; Laura Herrero; Dolors Serra
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

Review 10.  Social defeat models in animal science: What we have learned from rodent models.

Authors:  Atsushi Toyoda
Journal:  Anim Sci J       Date:  2017-04-24       Impact factor: 1.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.